871348-24-2
C29H52O7SSi2
600.96
1.07
99% min
N/A
N/A
N/A
L (Breast cancer; sarcoma; liposarcoma)
Eribulin
7/8/2027 (Eribulin)
Availability: | |
---|---|
Synthetic Roadmap
Are also in this series, click those CAS No. above
To check details
Illustrate
For the synthesis of Eribulin, Eribulin belongs to a new type of drug for the treatment of breast cancer. We offer high purity, kilogram production.
Download